Sort
30,917 grants matching “tumor microenvironment”
Defining the impact of stromal aging on ovarian cancer initiation
$448,951Lan Coffman · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · AG
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
$448,905Jenny C-N Chang · Methodist Hospital Research Institute · U01 · FY2022 · CA
Biopsychosocial predictors of tumor-associated inflammation and progression
$448,825Eida Maria Castro · Ponce School Of Medicine · U54 · FY2021 · MD
Modulation of Therapeutic Response
$448,821James B Mitchell · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Nutrient sensing and lysosomal signaling in regulatory T cells and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2022 · AI
Nutrient sensing and lysosomal signaling in regulatory T cells and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2020 · AI
Hippo signaling in stable regulatory activity and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2018 · AI
Hippo signaling in stable regulatory activity and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2020 · AI
Hippo signaling in stable regulatory activity and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2022 · AI
Nutrient sensing and lysosomal signaling in regulatory T cells and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2021 · AI
Hippo signaling in stable regulatory activity and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2019 · AI
Nutrient sensing and lysosomal signaling in regulatory T cells and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2023 · AI
Hippo signaling in stable regulatory activity and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2021 · AI
Nutrient sensing and lysosomal signaling in regulatory T cells and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2019 · AI
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance
$448,510Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer
$448,439Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Collaborative Research: CPS: Medium: A CPS approach to tumor immunomodulation; sensing, analysis, and control to prime tumors to immunotherapy
$448,428Rahul A Sheth · University Of Texas, M.D. Anderson Cancer Center · · FY2021 · CSE
Non-invasive Quantification of Dose-Exposure-Response of PD-L1 Therapeutics at the Tumor
$448,389Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2022 · CA
Transport Oncophysics Core
$448,357Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA
Biopsychosocial predictors of tumor-associated inflammation and progression
$448,308Eida Maria Castro · Ponce School Of Medicine · U54 · FY2022 · MD
Epigenetic Therapy for Thoracic Malignanceis
$448,245David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers
$448,200Catherine C Hedrick · La Jolla Institute For Immunology · U01 · FY2020 · CA
TARGETING MYCOBIOME METABOLISM TO REPROGRAM THE IMMUNOSUPPRESSIVE PANCREATIC TUMOR MICROENVIRONMENT
$448,133Regents Of The University Of Michigan · · FY2025 · Defense Health Agency
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors
$448,088Melissa L Fishel · Indiana University Indianapolis · R01 · FY2021 · CA
Molecular imaging and system dynamics of tumor virotherapy
$448,060David J Dingli · Mayo Clinic Rochester · R01 · FY2014 · CA